TRIM14 and gastric cancer: These findings suggest that TRIM14 is an activator of the EMT process in GC, which regulates the transition of epithelial cells to the mesenchymal phenotype by activating AKT signaling, thereby promoting the migration and invasion of gastric cancer (30).